 Michael Shirts
Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Dynamics Simulation | 18 | 2023 | 200 | 6.310 |
Why?
| | Thermodynamics | 28 | 2023 | 380 | 4.010 |
Why?
| | Muramidase | 4 | 2020 | 72 | 1.690 |
Why?
| | Proteins | 12 | 2023 | 906 | 1.520 |
Why?
| | Solvents | 10 | 2020 | 104 | 1.270 |
Why?
| | Protein Folding | 3 | 2022 | 239 | 0.880 |
Why?
| | Bayes Theorem | 2 | 2022 | 327 | 0.840 |
Why?
| | Ligands | 10 | 2023 | 556 | 0.840 |
Why?
| | Computer Simulation | 12 | 2022 | 873 | 0.840 |
Why?
| | Models, Molecular | 7 | 2022 | 1368 | 0.840 |
Why?
| | Water | 5 | 2016 | 394 | 0.830 |
Why?
| | Terpenes | 1 | 2022 | 21 | 0.820 |
Why?
| | Liquid Crystals | 1 | 2022 | 36 | 0.800 |
Why?
| | Nucleic Acids | 1 | 2022 | 58 | 0.770 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2012 | 445 | 0.620 |
Why?
| | Protein Binding | 14 | 2021 | 1888 | 0.620 |
Why?
| | Monte Carlo Method | 5 | 2022 | 136 | 0.580 |
Why?
| | Amides | 2 | 2021 | 87 | 0.570 |
Why?
| | Models, Chemical | 8 | 2016 | 248 | 0.560 |
Why?
| | Imidazoles | 3 | 2020 | 203 | 0.550 |
Why?
| | Bacteriophage T4 | 2 | 2013 | 15 | 0.550 |
Why?
| | Drug Design | 5 | 2016 | 147 | 0.540 |
Why?
| | Selenium Compounds | 1 | 2016 | 21 | 0.520 |
Why?
| | Quantum Dots | 1 | 2016 | 34 | 0.510 |
Why?
| | T-Lymphocytes | 1 | 2023 | 1735 | 0.510 |
Why?
| | Cadmium Compounds | 1 | 2016 | 30 | 0.510 |
Why?
| | Nanotubes, Carbon | 1 | 2016 | 42 | 0.500 |
Why?
| | Bridged-Ring Compounds | 2 | 2020 | 9 | 0.500 |
Why?
| | Dextrans | 1 | 2015 | 73 | 0.470 |
Why?
| | Ethers, Cyclic | 1 | 2014 | 7 | 0.460 |
Why?
| | Resorcinols | 1 | 2014 | 4 | 0.460 |
Why?
| | Carboxylic Acids | 1 | 2014 | 26 | 0.450 |
Why?
| | Catalytic Domain | 3 | 2023 | 196 | 0.450 |
Why?
| | HIV Reverse Transcriptase | 1 | 2013 | 29 | 0.440 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2013 | 82 | 0.420 |
Why?
| | Binding Sites | 6 | 2016 | 1166 | 0.410 |
Why?
| | Protein Structure, Secondary | 3 | 2023 | 325 | 0.400 |
Why?
| | Insulin | 1 | 2022 | 2080 | 0.400 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 55 | 0.390 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2012 | 159 | 0.370 |
Why?
| | Benchmarking | 2 | 2023 | 162 | 0.370 |
Why?
| | Peptide Fragments | 2 | 2012 | 665 | 0.350 |
Why?
| | Enzyme Inhibitors | 2 | 2023 | 743 | 0.330 |
Why?
| | Amino Acids | 2 | 2021 | 445 | 0.330 |
Why?
| | RNA-Binding Proteins | 1 | 2012 | 344 | 0.330 |
Why?
| | Quantum Theory | 3 | 2020 | 78 | 0.320 |
Why?
| | Tacrolimus Binding Protein 1A | 2 | 2007 | 7 | 0.310 |
Why?
| | Protein Conformation | 5 | 2015 | 803 | 0.300 |
Why?
| | Software | 3 | 2018 | 526 | 0.300 |
Why?
| | Allosteric Site | 2 | 2023 | 16 | 0.270 |
Why?
| | Data Interpretation, Statistical | 1 | 2008 | 318 | 0.270 |
Why?
| | Tacrolimus | 1 | 2007 | 134 | 0.270 |
Why?
| | Peptides | 3 | 2023 | 847 | 0.260 |
Why?
| | Energy Transfer | 1 | 2005 | 47 | 0.240 |
Why?
| | Mammals | 2 | 2023 | 241 | 0.240 |
Why?
| | Mutation | 2 | 2023 | 3338 | 0.240 |
Why?
| | Entropy | 4 | 2023 | 35 | 0.230 |
Why?
| | Drug Discovery | 3 | 2016 | 123 | 0.230 |
Why?
| | Adsorption | 2 | 2015 | 120 | 0.230 |
Why?
| | Molecular Structure | 4 | 2021 | 434 | 0.230 |
Why?
| | Bias | 1 | 2005 | 178 | 0.220 |
Why?
| | Hydrogen Bonding | 2 | 2022 | 143 | 0.220 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2023 | 15 | 0.220 |
Why?
| | Molecular Conformation | 4 | 2021 | 135 | 0.210 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 147 | 0.200 |
Why?
| | Petroselinum | 1 | 2021 | 1 | 0.190 |
Why?
| | Dimerization | 1 | 2022 | 176 | 0.190 |
Why?
| | Polysaccharides | 1 | 2022 | 78 | 0.190 |
Why?
| | Models, Theoretical | 3 | 2020 | 513 | 0.190 |
Why?
| | Cellulase | 2 | 2012 | 30 | 0.190 |
Why?
| | Macrocyclic Compounds | 1 | 2020 | 9 | 0.170 |
Why?
| | Uncertainty | 3 | 2016 | 91 | 0.170 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2020 | 345 | 0.160 |
Why?
| | Methane | 2 | 2013 | 43 | 0.160 |
Why?
| | Reproducibility of Results | 3 | 2018 | 2764 | 0.160 |
Why?
| | Algorithms | 4 | 2013 | 1469 | 0.150 |
Why?
| | Cyclohexanes | 1 | 2016 | 22 | 0.140 |
Why?
| | Electrons | 1 | 2016 | 71 | 0.130 |
Why?
| | Biophysics | 2 | 2006 | 69 | 0.120 |
Why?
| | Chromatography, Ion Exchange | 1 | 2015 | 48 | 0.120 |
Why?
| | Porosity | 1 | 2015 | 88 | 0.120 |
Why?
| | Static Electricity | 1 | 2015 | 112 | 0.120 |
Why?
| | Diffusion | 1 | 2015 | 119 | 0.120 |
Why?
| | Motion | 1 | 2015 | 92 | 0.120 |
Why?
| | Pharmaceutical Preparations | 1 | 2016 | 164 | 0.120 |
Why?
| | Glucosidases | 1 | 2013 | 3 | 0.110 |
Why?
| | Rilpivirine | 1 | 2013 | 3 | 0.110 |
Why?
| | Oligosaccharides | 1 | 2013 | 46 | 0.110 |
Why?
| | Nevirapine | 1 | 2013 | 16 | 0.110 |
Why?
| | Periodicity | 1 | 2013 | 54 | 0.110 |
Why?
| | Kinetics | 2 | 2015 | 1547 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2013 | 177 | 0.100 |
Why?
| | Nitriles | 1 | 2013 | 149 | 0.100 |
Why?
| | Biophysical Phenomena | 1 | 2013 | 63 | 0.100 |
Why?
| | Molecular Docking Simulation | 1 | 2012 | 101 | 0.100 |
Why?
| | Toluene | 1 | 2012 | 11 | 0.100 |
Why?
| | Deuterium Exchange Measurement | 1 | 2011 | 29 | 0.090 |
Why?
| | Complementarity Determining Regions | 1 | 2011 | 43 | 0.090 |
Why?
| | Trichoderma | 1 | 2011 | 24 | 0.090 |
Why?
| | Alanine | 1 | 2011 | 105 | 0.090 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2011 | 69 | 0.090 |
Why?
| | Carbohydrates | 1 | 2011 | 55 | 0.090 |
Why?
| | Pyrimidines | 1 | 2013 | 374 | 0.090 |
Why?
| | Fungal Proteins | 1 | 2011 | 119 | 0.090 |
Why?
| | Piperazines | 1 | 2012 | 310 | 0.090 |
Why?
| | Chemistry, Physical | 2 | 2006 | 37 | 0.080 |
Why?
| | Ethanol | 1 | 2013 | 534 | 0.080 |
Why?
| | Laboratories | 1 | 2008 | 95 | 0.070 |
Why?
| | Computational Biology | 1 | 2011 | 528 | 0.070 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2011 | 660 | 0.070 |
Why?
| | Time Factors | 3 | 2013 | 6077 | 0.060 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2005 | 16 | 0.060 |
Why?
| | Humans | 8 | 2022 | 114078 | 0.060 |
Why?
| | Substrate Specificity | 2 | 2013 | 350 | 0.050 |
Why?
| | DNA | 1 | 2008 | 1350 | 0.050 |
Why?
| | Solubility | 2 | 2016 | 223 | 0.050 |
Why?
| | Circular Dichroism | 1 | 2021 | 135 | 0.050 |
Why?
| | Physical Phenomena | 1 | 2020 | 12 | 0.040 |
Why?
| | Temperature | 2 | 2011 | 564 | 0.040 |
Why?
| | Ecosystem | 1 | 2021 | 500 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2016 | 79 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2016 | 499 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2015 | 241 | 0.030 |
Why?
| | Dextrins | 1 | 2012 | 3 | 0.030 |
Why?
| | Cellobiose | 1 | 2012 | 6 | 0.030 |
Why?
| | Animals | 2 | 2023 | 31570 | 0.030 |
Why?
| | Glycoside Hydrolases | 1 | 2012 | 30 | 0.020 |
Why?
| | Cellulose | 1 | 2012 | 57 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 2011 | 122 | 0.020 |
Why?
| | Freezing | 1 | 2011 | 84 | 0.020 |
Why?
| | Bevacizumab | 1 | 2011 | 114 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 156 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2011 | 157 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2011 | 622 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 1981 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2783 | 0.020 |
Why?
| | Probability | 1 | 2006 | 286 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1257 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 176 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2006 | 452 | 0.020 |
Why?
| | Models, Statistical | 1 | 2006 | 595 | 0.010 |
Why?
| | Viscosity | 1 | 2003 | 81 | 0.010 |
Why?
| | Microfilament Proteins | 1 | 2003 | 125 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 1837 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2003 | 527 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 694 | 0.010 |
Why?
|
|
Shirts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|